Sorry, this entry is only available in Russian.
Вас может заинтересовать:
German BioNTech has announced plans to market the world's first cancer vaccines. Obtaining a license for such drugs is expected in 2026. This was announced by BioNTech co-founders Ozlem Tureci…
Editorial
The concepts of digitalization and automation are changing the way pharmaceutical production is done, and are enabling companies to bring their products to market faster and deliver medicines to patients.…
